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ABSTRACT 
 
Background and Objectives: Serratia marcescens, a potentially pathogenic bacterium, benefits from its swarming motility 
and resistance to antibiotic as two important virulence factors. Inappropriate use of antibiotics often results in drug resistance 
phenomenon in bacterial population. Use of probiotic bacteria has been recommended as partial replacement. In this study, 
we investigated the effects of some lactobacilli culture supernatant on swarming, motility and antibiotic resistance of S. 
marcescens.
Materials and Methods: Antimicrobial activity of lactobacilli supernatant and susceptibility testing carried out on S. marc-
escens isolates. Pretreatment effect of lactobacilli culture supernatant on antibiotic - resistance pattern in S. marcescens was 
determined by comparison of the MIC of bacteria before and after the treatment. 
Results: Our results showed that pretreatment with L. acidophilus ATCC 4356 supernatant can affect the resistance of Ser-
ratia strains against ceftriaxone, but it had no effect on the resistance to other antibiotics. Furthermore, culture supernatant 
of lactobacilli with concentrations greater than 2%, had an effect on the swarming ability of S. marcescens ATCC 13880 and 
inhibited it.
Conclusion: Probiotic bacteria and their metabolites have the ability to inhibit virulence factors such as antibiotic resistance 
and swarming motility and can be used as alternatives to antibiotics. 
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INTRODUCTION
Serratia marcescens is an important opportunistic 
pathogen of humans (1). It is a major cause of hospi-
tal-acquired pneumonia, urinary tract infections, re-
spiratory tract infections, bacteremia, conjunctivitis, 
endocarditis, meningitis and wound infections (2-4). 
http://ijm.tums.ac.ir
S. marcescens swarming motility is a surface-associ-
ated group behavior that is connected with virulence 
capability and antibiotic resistance (5, 6). Swarming 
motility has been noted as the cause of virulence for 
other Gram-negative bacteria such as Pseudomonas 
aeruginosa (7). S. marcescens flagella and surfac-
tants, known as serrawettins, contribute to swarming 
motility (8-10). S. marcescens swarms on Luria-Ber-
tani (LB) agar surfaces at 30°C, but not at 37°C (11). 
Increased resistance among pathogens, causing nos-
ocomial and community acquired infections, has 
been attributed to the widespread usage of antibiot-
ics (12). The main problem associated with S. marc-
escens infections is increase in its resistance against 
various antibiotics (13). Therefore, it is essential to 
find new therapeutic approach for the treatment of 
such infections. Preparing prevention and treatment 
protocols with using natural products seems to be 
necessary (14). Recent reports have documented the 
role of Lactobacillus in the prevention and treatment 
of some infections. Lactobacillus species and strains 
live as commensals in the human body (15). Their 
beneficial effect may be associated to their ability to 
inhibit the growth of pathogens, apparently by the 
secretion of antibacterial substances including lactic 
acid, hydrogen peroxide, etc. (16). Nowadays, appli-
cation of probiotics for prevention and management 
of gastrointestinal disorders has received much in-
terest (17). In this study, due to the increasing an-
tibiotic resistance, especially among Gram-negative 
bacteria the inhibitory effects of several lactobacilli 
culture supernatants on some S. marcescens strains 
virulence factors was investigated after producing 
susceptible phenotype as a new way for treating  an-
tibiotic resistance pathogens.
 
MATERIALS AND METHODS
  
   Bacterial strains and culture conditions. Lac-
tobacillus plantarum ATCC 8014, L. acidophilus 
ATCC 4356, S. marcescens ATCC13880 and S. mar-
cescens ATCC 19180 were purchased from Iranian 
Research Organization for Science and Technology 
(IROST). The Lactobacillus species were grown 
in the Man, Rogosa, Sharpe Broth (MRSB; Darm-
stadt, Merck, Germany) and incubated at 37°C in 
an anaerobic jar for 24 h and maintained on MRS 
agar plates (MRSA; Darmstadt, Merck, Germany). 
S. marcescens strains were grown in Nutrient Broth 
(NB; Darmstadt, Merck, Germany) and incubated at 
37°C for 24 h.
Antimicrobial activity and nature of antimicro-
bial substances in lactobacilli supernatant. The 
inhibitory activity of supernatants of L. acidophi-
lus and L. plantarum was screened against S. mar-
cescens strains using Micro scale Optical Density 
Assay (MODA) (18). Cell-free culture supernatants 
(CFCS) were obtained by centrifugation (13,000 × g, 
4°C and 15 min) of L. acidophilus and L. plantarum 
cultures grown in 20 ml MRS broth at 37°C for 24 
h. The supernatant was filtered through a 0.22 mm 
filter to remove cells, and then 1 ml CFCS of L. aci-
dophilus and L. plantarum was retained as untreated 
filtrate. To determine the effect of organic acids, 1 ml 
CFCS was adjusted to pH 7. The neutralized CFCS 
was then treated with catalase (5 mg ml-1, Sigma) at 
25°C for one h to eliminate the possible inhibitory ef-
fect of H2O2. Pepsin and trypsin sensitivity was eval-
uated by incubating one ml CFCS with proteolytic 
enzymes, including Pepsin (1 mg ml-1, Sigma) and 
Trypsin (1 mg ml-1, Sigma) at 37°C for 2 h. Briefly, 
in a 96 well plate, 100 µl of diluted (1:10,000 in NB) 
test culture was added. Triplicate wells for each test 
culture, one well which nothing was added (no su-
pernatant or media) just 100 µl of diluted test culture; 
one well, served as a negative control, in which 15 
µl of MRS was added; and the third well served as 
the test well to which 15 µl of cell-free L. plantarum 
or L. acidophilus treated supernatant (with NaOH, 
H2O2, Pepsin and Trypsin) were added. Each series 
was run in duplicate on the same plate. The plate was 
then incubated at 37°C for 24 h. After incubation, 
plates were read using a micro plate reader at 600 
nm. The difference in absorbance between control 
(media) and samples were used to report antibacte-
rial activity as percent difference in cell growth (18).
Susceptibility testing. The minimum inhibitory 
concentrations (MICs) were determined according 
to the clinical laboratory Standards Institute (CLSI) 
guideline (2015) using micro titer plate method. In 
this method, colonies of lactobacilli from TSA were 
suspended in Muller Hinton broth (Merck, Germany) 
and the turbidity of suspension was adjusted to 0.5 
McFarland and subsequently diluted in Muller Hin-
ton broth (1:100) to reach a final concentration of 1 
× 106 CFU/ml. Dilutions of cephalothin (Sigma-Al-
drich), cefazolin, amikacin, ceftriaxone and ceftazi-
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dime (Exir, Broujerd, Iran) were made in distilled 
water. The antibiotics were prepared at different 
concentrations ranged from 0.125 to 512 µg/ml. Each 
well was filled with 100 µl of each dilution of the an-
tibiotic and 100 µl of bacterial suspension. Each plate 
included positive controls (bacteria without an anti-
microbial), negative controls (medium only). Micro 
titer plates were incubated at 37°C for 24 h. MIC was 
determined as the minimum antibiotic concentration 
that inhibited the visible growth (19). All tests were 
carried out in duplicates.
Determination of MIC of lactobacilli superna-
tant against S. marcescens strains. The MIC of the 
supernatant was determined according to Wikler et 
al. (2015) method with some modifications (19). In 
brief, the highest and the lowest concentrations were 
250 µg/ml and 0.5 µg/ml respectively. Moreover, 
the supernatant was directly added to the wells. A 
stock solution of supernatant was prepared in sterile 
Muller- Hinton broth (256 µg/ml) which was further 
diluted in MHB to reach concentration range of 0.5 
µg/ml to 256 µg/ml. Afterwards, 100 µl culture of 
one of the test bacteria, grown to the early stationary 
growth phase in MHB, was added to 1 ml of MHB in 
tube and final concentration of bacteria in individual 
tubes was adjusted to about 5 × 106 CFU/ml. Con-
trol tubes contained; only culture media without any 
antibacterial agent, culture media with pathogenic 
strains (5 × 106 CFU/ml), and culture media with su-
pernatant. After 24 h incubation at 37°C, the MIC 
was determined as lowest concentration that could 
inhibit visible bacterial growth for 24 h (20, 21).
Pretreatment effect of lactobacilli culture super-
natant on antibiotic-resistant pattern in S. marc-
escens. The MICs of lactobacilli culture supernatant 
were determined as explained above. Then S. marc-
escens strains were cultured in sub-MIC (1/2 MIC) 
concentrations of the supernatant. After incubation 
at 37°C for 18 h, bacteria were cultured in LB broth 
medium and were incubated until achieving 0.5 Mc-
Farland standards and then the amount of MIC was 
determined for antibiotics according to Wikler et al. 
(19). Finally, the MIC of antibiotics for bacteria was 
compared before and after the treatment (22, 23).
Assay of swarming inhibition. Standard NC-
CLS agar dilution method was used to test the an-
ti-swarming activity of lactobacilli supernatant (24). 
L. acidophilus ATCC 4356 and L. plantarum ATCC 
8014 were cultured in the Man, Rogosa, Sharpe 
Broth or agar and incubated at 37°C in an anaerobic 
jar for 24 h. The supernatant of overnight cultures of 
L. acidophilus and L. plantarum was separated and 
neutralized by catalase (5 mg/ml-1) and trypsin (1mg/
ml-1). Various concentrations of supernatants (rang-
ing from 0.5% to 4% v/v) were added to the PG (pep-
tone glycerol [peptone, 5 g/liter; glycerol, 1% v/v; 
agar-agar 0.7%]) (25). Plates were inoculated with 
3 μl (108 CFU/ml-1) of S. marcescens ATCC 13880, 
and incubated at 30oC. Growth and swarming were 
monitored after 24 h. The supernatant neutralized by 
NaOH (1N), catalase (5 mg/ml-1) and trypsin (1mg/
ml-1), then used as the control of growth (26).
Statistical analysis. SPSS version 20 was used for 
statistical analysis. The result of triplicate experi-
ments was averaged, and significance level was set at 
P < 0.05. Then one way analysis of variance (ANO-
VA) was performed for comparing between groups.
 
RESULTS
The antimicrobial activity and nature of anti-
microbial substances of lactobacilli supernatant. 
The data presented in Figs. 1 and 2 show the inhibi-
tory activity of the L. plantarum and L. acidophilus 
supernatants measured by MODA. Comparison of 
the non-treated supernatant of both strains with that 
of the control (MRS medium) revealed an inhibito-
ry effect of the supernatant from both strains on S. 
marcescens ATCC 13880 and S. marcescens ATCC 
19180. Then the supernatant of both strains of Lacto-
bacillus were neutralized with catalase, trypsin, and 
NaOH compared with the control. The results indi-
cated that organic acids and proteinaceous compo-
nents had a significant role in the antimicrobial activ-
ity of the supernatant (p < 0.05), but the neutralized 
supernatant of both strains of lactobacilli with NaOH 
and trypsin had no significant antimicrobial activity 
(p > 0.05).
Determination of MICs. The MIC breakpoint of 
≥ 4µg/ml considers as resistance of bacterium to ce-
fazolin and ceftriaxone and the MIC breakpoint of ≤ 
1µg/ml indicates the susceptibility of bacterium to 
these antibiotics (Table 1). The MIC breakpoint of ≥ 
16µg/ml, ≥ 64µg/ml and ≥ 32µg/ml shows ceftazi-
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dim, amikacin and cephalotin resistance respectively 
in the bacterial strain and the MIC breakpoint ≤ 4µg/
ml, ≤ 16µg/ml and ≤ 8µg/ml explained the suscepti-
bility to these antibiotics respectively. Consequently, 
both S. marcescens strains were resistant to cephalo-
tin, ceftazidim, ceftriaxon but susceptible to Amika-
cin. On the other hand, S. marcescens ATCC 13880 
was resistant and S. marcescens ATCC 19180 was 
susceptible to cefazolin.
Determination of MIC of lactobacilli superna-
tant against S. marcescens strains. MIC of cell free 
supernatant of Lactobacillus strains has been shown 
in Table 2. 
The effect of lactobacilli culture supernatant 
pretreatment on antibiotic-resistant pattern in S. 
marcescens. Table 3 shows the MICs of treated S. 
marcescens strains with sub-MIC concentrations of 
each lactobacilli culture supernatants. It was found 
that L. acidophilus and L. plantarum culture super-
natant treated strains of S. marcescens remained 
unchanged to cephalothin, cefazolin, amikacin and 
ceftazidime compared with non- treated. While, 
the sensitivity of S. marcescens strains to ceftriax-
Fig. 1. MODA of cell-free supernatant from L. acidophilus ATCC 4356 on S. marcescens strains growth.
Fig. 2. MODA of cell-free supernatant from L. plantarum ATCC 8014 on S. marcescens strains growth.
Table 1. Minimum Inhibitory Concentrations (MICs) of an-
tibiotics against S. marcescens strains (0.125 to 512 µg/ml)
Antibiotic
Cephalothin
Cefazolin
Amikacin
Ceftriaxone 
Ceftazidime
MIC breakpoint
(µg/ml)
S. marcescens 
ATCC 13880          
S. marcescens 
ATCC 19180
512
64
1
128
512
512
0.125
0.125
64
512
Table 2. Minimum Inhibitory Concentrations (MICs) of lac-
tobacilli supernatant against S. marcescens strains (0.5 µg/
ml to 256 µg/ml)
Cell free supernatant 
of
Lactobacillus strains
L. plantarum 
ATCC 8014
L. acidophilus 
ATCC 4356
MIC breakpoint
(µg/ml)
S. marcescens 
ATCC 13880        
S. marcescens 
ATCC 19180
64
16
32
8
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one after treatment with L. acidophilus supernatant 
changed.
Effects on swarming motility. Treated superna-
tant of L. acidophilus ATCC 4356 and L. plantarum 
ATCC 8014 with NaOH and Trypsin had no effect on 
swarming motilities (Figs. 3 and 4). While concen-
trations of 4% and 2% of supernatant of both strains 
of lactobacilli without treating, completely inhibited 
swarming motility. Swarming inhibition by 1% v/v 
was more apparent than by 0.5% v/v and the control 
plate showed no inhibition of swarming.
DISCUSSION
   In recent decades, worldwide overuse and non-pru-
dent use of antibiotics are leading to the global health 
care issue of antibiotic resistance. Resistance to com-
mon antibiotics in the treatment of nosocomial in-
fection caused by bacteria has increased and created 
serious problems in the treatment of these diseases. 
S. marcescens is a growing problem for public health, 
because of its high resistance against many antibiotics 
and its increasing role in hospital acquired infections. 
It is important to prevent the spreading of bacteria 
Table 3. Minimum Inhibitory Concentrations (MICs) of antibiotics against S. marcescens strains after 24 h treatment with 
lactobacilli culture supernatant (0.125 to 512 µg/ml)
Treated with  
L. plantarum 
Supernatant
512
0.125
0.125
64
512
Treated with  
L. acidophilus 
Supernatant
512
0.125
0.125
32
512
Treated with  
L. plantarum  
Supernatant
512
64
1
128
512
Treated with  
L. acidophilus 
Supernatant
512
64
1
64
512
Antibiotic
Cephalothin
Cefazolin
Amikacin
Ceftriaxone
Ceftazidime
      S. marcescens ATCC 13880                         S. marcescens ATCC 19180
Fig. 4. Swarming motilities were assayed in PG (peptone glycerol [peptone, 5 g/liter; glycerol, 1% v/v; agar-agar 0.7%]) con-
taining concentrations of L. plantarum ATCC 8014 supernatant ranging from 0.5% to 4% v/v. Plates were photographed after 
24 h of incubation at 30oC. a) Control contained treated supernatant with NaOH and Trypsin. b, c, d and e) Test containing 
0.5%, 1%, 2% and 4% of supernatant, respectively.
Fig. 3. Swarming motilities were assayed in PG (peptone glycerol [peptone, 5 g/l; glycerol, 1% v/v; agar-agar 0.7%]) contain-
ing concentrations of L. acidophilus ATCC 4356 supernatant ranging from 0.5% to 4% v/v. Plates were photographed after 24 
h of incubation at 30oC. a) Control contained treated supernatant with NaOH and Trypsin. b, c, d and e) test containing 0.5%, 
1%, 2% and 4% of supernatant, respectively.
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from patient to patient (27). S. marcescens infections 
have high resistance against some cephalosporins, azt-
reonam and imipenem (28). In this research, the MICs 
of cephalosporins and amikacin against S. marcescens 
strains were measured (Table 1). Then, the MICs of 
antibiotics were measured after treating the Serratia 
strains with sub-MIC concentrations of lactobacilli 
supernatants (Table 3). According to our results, it can 
be deduced that L. acidophilus supernatant was able 
to change the antibiotic resistance patterns of S. mar-
cescens strains against ceftriaxone but had no effect 
on the other antibiotics resistance pattern. Treatment 
with L. acidophilus supernatant reduced the resistance 
of both strains of Serratia to ceftriaxone. Ceftriaxone 
inhibits the mucopeptide synthesis of the bacterial cell 
wall. In one study by Alakomi et al. (2000), it was 
found that lactic acid produced by Lactobacillus 
strains can increase the susceptibility of Gram-nega-
tive bacteria to the antimicrobial agents (28). Such ef-
fect on ceftriaxone resistance may be associated with 
lactic acid or proteinaceous component of the lactoba-
cilli supernatants on bacterial cell wall permeability 
and there was an indirect relationship between the pH 
value of lactobacilli supernatants and penetration of 
antibiotics into the bacterium. Similar work was done 
in this field by Naderi et al. (2014), who found that 
pretreatment with lactobacilli supernatants could be 
effective on some antibiotic resistant Gram negative 
bacteria such as E. coli, but not Klebsiella spp and 
Entrobacter (22). In another study by Shahriar et al. 
(2012), pretreatment with Sodium Dodecyl Sulfate 
(SDS) and acridine orange did not affect the antibiotic 
resistance patterns and plasmid isolation of Klebsiella 
spp (23). Taylor et al. (2002) suggested that the use of 
agents that do not kill pathogenic bacteria, but modify 
them to produce a susceptible phenotype to antibiotic 
could be an alternative approach to the treatment of 
infectious disease (29). Such agents could render the 
pathogen susceptible to a previously ineffective anti-
biotic, and because the modifying agent applies little 
or no direct selective pressure, this concept could slow 
down or prevent the emergence of resistant genotypes. 
The search for solutions to the global problem of an-
tibiotic resistance in pathogenic bacteria has often fo-
cused on the isolation and characterization of new an-
timicrobial compounds from a variety of sources such 
as probiotic bacteria. Large varieties of compounds 
produced by lactobacilli have proved to have thera-
peutic potentials as antimicrobials and as resistance 
modifiers. 
   S. marcescens is an important nosocomial patho-
gen that possesses a repertoire of virulence factors 
and displays multicellular behavior such as swarming 
and biofilm formation. Swarming of Serratia has been 
implicated in pathogenesis (11, 28). The increasing 
evidence of antibiotic resistance requires developing 
alternative strategies for treatment. This study aimed 
to find lactobacilli supernatant with antibacterial po-
tentials in order to control antibiotic resistant patho-
gens. We showed that treated supernatant of both 
lactobacilli strains with trypsin and catalase has the 
ability to inhibit S. marcescens swarming significantly 
in concentration greater than 2% and inhibited swarm-
ing completely at 4%. But concentration less than 1% 
had no effect on swarming motility (Figs. 3 and 4). On 
the other hand, treated supernatant with Trypsin and 
NaOH significantly affect the growth of both Serratia 
strains (Figs. 1 and 2). The results indicate that organ-
ic acid and proteinaceous components both had effect 
on growth of Serratia while NaOH neutralized super-
natant had no effect on swarming. This confirms direct 
impact of the organic acids of the supernatant. Similar 
works with similar results have also been reported by 
Roshid et al. (2014), Inoue et al. (2008) and Ghaidaa 
et al. (2013), who found several agents such as: plants 
extract, fatty acids and p-nitrophenylglycerol are ef-
fective on swarming of pathogenic bacteria including 
Proteus and P. aeruginosa (30-32).
   It is now well known that many bacterial functions 
including swarming, biofilm formation, and secretion 
of virulence factors that are important in successful 
and recurrent establishment of bacterial infections 
are related to quorum sensing (QS) (33, 34). Thus, 
inhibiting QS or anti-QS is an important anti- infec-
tious measure that does not rely on antibiotics (35). 
Anti-QS agents will inhibit QS mechanism, attenu-
ate virulence determinants and are unlikely to cause 
drug-resistance related problems (36). With the ap-
pearance of multi antibiotic-resistant bacteria; it is 
becoming increasingly more difficult to treat bacterial 
infections with conventional antibiotics. Thus, there is 
an increasing need for new strategies to cope with in-
fectious diseases. It has been suggested that inactivat-
ing the QS system of a pathogen can result in a signifi-
cant decrease in virulence factor production (37- 39). 
So, the possible mechanism by which supernatant of 
lactobacilli could inhibit S. marcescens swarming and 
virulence factor expression may be due to its acting as 
an inhibitor compound for bacterial quorum sensing 
(40, 41). 
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